Page 1198 - Williams Hematology ( PDFDrive )

1172 Part IX: Lymphocytes and Plasma Cells Chapter 75: Functions of B Lymphocytes and Plasma Cells in Immunoglobulin Production 1173

43. Lieber MR: The mechanism of double-strand DNA break repair by the nonhomologous 78. Dudley DD, Chaudhuri J, Bassing CH, Alt FW: Mechanism and control of V(D)
DNA end-joining pathway. Annu Rev Biochem 79:181, 2010. J recombination versus class switch recombination: Similarities and differences. Adv
44. Rooney S, Chaudhuri J, Alt FW: The role of the non-homologous end-joining pathway Immunol 86:43, 2005.
in lymphocyte development. Immunol Rev 200:115, 2004. 79. Revy P, Muto T, Levy Y, et al: Activation-induced cytidine deaminase (AID) defi-
45. Gostissa M, Alt FW, Chiarle R: Mechanisms that promote and suppress chromosomal ciency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell
translocations in lymphocytes. Annu Rev Immunol 29:319, 2011. 102:565, 2000.
46. Nussenzweig A, Nussenzweig MC: Origin of chromosomal translocations in lymphoid 80. Zahn A, Eranki AK, Patenaude AM, et al: Activation induced deaminase C-terminal
cancer. Cell 141:27, 2010. domain links DNA breaks to end protection and repair during class switch recombina-
47. Helmink BA, Sleckman BP: The response to and repair of RAG-mediated DNA tion. Proc Natl Acad Sci U S A 111:E988, 2014.
double-strand breaks. Annu Rev Immunol 30:175, 2012. 81. Imai K, Slupphaug G, Lee WI, et al: Human uracil-DNA glycosylase deficiency asso-
48. Steen SB, Gomelsky L, Speidel SL, Roth DB: Initiation of V(D)J recombination in vivo: ciated with profoundly impaired immunoglobulin class-switch recombination. Nat
Role of recombination signal sequences in formation of single and paired double- Immunol 4:1023, 2003.
strand breaks. EMBO J 16:2656, 1997. 82. Kaji T, Furukawa K, Ishige A, et al: Both mutated and unmutated memory B cells accu-
49. Jones JM, Simkus C: The roles of the RAG1 and RAG2 “non-core” regions in V(D)J mulate mutations in the course of the secondary response and develop a new antibody
recombination and lymphocyte development. Arch Immunol Ther Exp (Warsz) 57:105, repertoire optimally adapted to the secondary stimulus. Int Immunol 25:683, 2013.
2009. 83. Michael N, Martin TE, Nicolae D, et al: Effects of sequence and structure on the hyper-
50. Tsai CL, Drejer AH, Schatz DG: Evidence of a critical architectural function for the mutability of immunoglobulin genes. Immunity 16:123, 2002.
RAG proteins in end processing, protection, and joining in V(D)J recombination. 84. Di Noia JM, Neuberger MS: Molecular mechanisms of antibody somatic hypermuta-
Genes Dev 16:1934, 2002. tion. Annu Rev Biochem 76:1, 2007.
51. Ciubotaru M, Trexler AJ, Spiridon LN, et al: RAG and HMGB1 create a large bend in 85. Peled JU, Kuang FL, Iglesias-Ussel MD, et al: The biochemistry of somatic hypermuta-
the 23RSS in the V(D)J recombination synaptic complexes. Nucleic Acids Res 41:2437, tion. Annu Rev Immunol 26:481, 2008.
2013. 86. Muramatsu M, Kinoshita K, Fagarasan S, et al: Class switch recombination and hyper-
52. Schatz DG, Spanopoulou E: Biochemistry of V(D)J recombination. Curr Top Microbiol mutation require activation-induced cytidine deaminase (AID), a potential RNA edit-
Immunol 290:49, 2005. ing enzyme. Cell 102:553, 2000.
53. Goodarzi AA, Jeggo PA: The repair and signaling responses to DNA double-strand 87. Buerstedde JM, Alinikula J, Arakawa H, et al: Targeting of somatic hypermutation by
breaks. Adv Genet 82:1, 2013. immunoglobulin enhancer and enhancer-like sequences. PLoS Biol 12:e1001831, 2014.
54. Khanna KK, Jackson SP: DNA double-strand breaks: Signaling, repair and the cancer 88. Aoufouchi S, Faili A, Zober C, et al: Proteasomal degradation restricts the nuclear life-
connection. Nat Genet 27:247, 2001. span of AID. J Exp Med 205:1357, 2008.
55. Le Deist F, Poinsignon C, Moshous D, et al: Artemis sheds new light on V(D)J recom- 89. Delker RK, Zhou Y, Strikoudis A, et al: Solubility-based genetic screen identifies RING
bination. Immunol Rev 200:142, 2004. finger protein 126 as an E3 ligase for activation-induced cytidine deaminase. Proc Natl
56. Gu Y, Sekiguchi J, Gao Y, et al: Defective embryonic neurogenesis in Ku-deficient but Acad Sci U S A 110:1029, 2013.
not DNA-dependent protein kinase catalytic subunit-deficient mice. Proc Natl Acad Sci 90. Storb U, Shen HM, Michael N, Kim N: Somatic hypermutation of immunoglobulin and
U S A 97:2668, 2000. non-immunoglobulin genes. Philos Trans R Soc Lond B Biol Sci 356:13, 2001.
57. Surucu B, Bozulic L, Hynx D, et al: In vivo analysis of protein kinase B (PKB)/Akt reg- 91. Allen CD, Cyster JG: Follicular dendritic cell networks of primary follicles and germi-
ulation in DNA-PKcs-null mice reveals a role for PKB/Akt in DNA damage response nal centers: Phenotype and function. Semin Immunol 20:14, 2008.
and tumorigenesis. J Biol Chem 283:30025, 2008. 92. Cook GP, Tomlinson IM: The human immunoglobulin VH repertoire. Immunol Today
58. Al-Hakim A, Escribano-Diaz C, Landry MC, et al: The ubiquitous role of ubiquitin in 16:237, 1995.
the DNA damage response. DNA Repair (Amst) 9:1229, 2010. 93. Kipps TJ: Human B cell biology. Int Rev Immunol 15:243, 1997.
59. Johnson K, Chaumeil J, Skok JA: Epigenetic regulation of V(D)J recombination. Essays 94. Frippiat JP, Williams SC, Tomlinson IM, et al: Organization of the human immuno-
Biochem 48:221, 2010. globulin lambda light-chain locus on chromosome 22q11.2. Hum Mol Genet 4:983,
60. Sleckman BP, Oltz EM: Preparing targets for V(D)J recombinase: Transcription paves 1995.
the way. J Immunol 188:7, 2012. 95. Kipps TJ, Carson DA: Autoantibodies in chronic lymphocytic leukemia and related
61. Subrahmanyam R, Sen R: Epigenetic features that regulate IgH locus recombination systemic autoimmune diseases. Blood 81:2475, 1993.
and expression. Curr Top Microbiol Immunol 356:39, 2012. 96. Jefferis R, Lefranc MP: Human immunoglobulin allotypes: Possible implications for
62. Chao J, Rothschild G, Basu U: Ubiquitination events that regulate recombination of immunogenicity. MAbs 1:332, 2009.
immunoglobulin Loci gene segments. Front Immunol 5:100, 2014. 97. Schanfield MS, Ferrell RE, Hossaini AA, et al: Immunoglobulin allotypes in Southwest
63. Grazini U, Zanardi F, Citterio E, et al: The RING domain of RAG1 ubiquitylates his- Asia: Populations at the crossroads. Am J Hum Biol 20:671, 2008.
tone H3: A novel activity in chromatin-mediated regulation of V(D)J joining. Mol Cell 98. Pandey JP: Immunoglobulin GM and KM allotypes and vaccine immunity. Vaccine
37:282, 2010. 19:613, 2000.
64. Jones JM, Bhattacharyya A, Simkus C, et al: The RAG1 V(D)J recombinase/ubiquitin 99. Muratori P, Sutherland SE, Muratori L, et al: Immunoglobulin GM and KM allotypes
ligase promotes ubiquitylation of acetylated, phosphorylated histone 3.3. Immunol Lett and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infec-
136:156, 2011. tion. J Virol 80:5097, 2006.
65. Kassmeier MD, Mondal K, Palmer VL, et al: VprBP binds full-length RAG1 and is 100. Magdelaine-Beuzelin C, Vermeire S, Goodall M, et al: IgG1 heavy chain-coding gene
required for B-cell development and V(D)J recombination fidelity. EMBO J 31:945, polymorphism (G1m allotypes) and development of antibodies-to-infliximab. Pharma-
2012. cogenet Genomics 19:383, 2009.
66. Simkus C, Bhattacharyya A, Zhou M, et al: Correlation between recombinase activating 101. Etto TL, Stewart LA, Muirhead J, et al: Kappa immunoglobulin light chain polymor-
gene 1 ubiquitin ligase activity and V(D)J recombination. Immunology 128:206, 2009. phisms and survival after allogeneic transplantation for B-cell malignancies: A poten-
67. Jiang H, Chang FC, Ross AE, et al: Ubiquitylation of RAG-2 by Skp2-SCF links destruc- tial graft-vs-leukaemia target. Tissue Antigens 69:56, 2007.
tion of the V(D)J recombinase to the cell cycle. Mol Cell 18:699, 2005. 102. van der Burg M, Barendregt BH, van Gastel-Mol EJ, et al: Unraveling of the polymor-
68. Rassenti LZ, Kipps TJ: Lack of allelic exclusion in B cell chronic lymphocytic leukemia. phic C lambda 2-C lambda 3 amplification and the Ke+Oz– polymorphism in the
J Exp Med 185:1435, 1997. human Ig lambda locus. J Immunol 169:271, 2002.
69. Tsuganezawa K, Kiyokawa N, Matsuo Y, et al: Flow cytometric diagnosis of the cell 103. Shimizu Y, Hendershot LM: Organization of the functions and components of the
lineage and developmental stage of acute lymphoblastic leukemia by novel monoclonal endoplasmic reticulum. Adv Exp Med Biol 594:37, 2007.
antibodies specific to human pre-B-cell receptor. Blood 92:4317, 1998. 104. Appenzeller-Herzog C, Ellgaard L: The human PDI family: Versatility packed into a
70. Bankovich AJ, Raunser S, Juo ZS, et al: Structural insight into pre-B cell receptor func- single fold. Biochim Biophys Acta 1783:535, 2008.
tion. Science 316:291, 2007. 105. van Anken E, Pena F, Hafkemeijer N, et al: Efficient IgM assembly and secretion require
71. Corcos D, Dunda O, Butor C, et al: Pre-B-cell development in the absence of lambda 5 the plasma cell induced endoplasmic reticulum protein pERp1. Proc Natl Acad Sci U S A
in transgenic mice expressing a heavy-chain disease protein. Curr Biol 5:1140, 1995. 106:17019, 2009.
72. Minegishi Y, Coustan-Smith E, Wang YH, et al: Mutations in the human lambda5/14.1 106. Anelli T, Ceppi S, Bergamelli L, et al: Sequential steps and checkpoints in the early
gene result in B cell deficiency and agammaglobulinemia. J Exp Med 187:71, 1998. exocytic compartment during secretory IgM biogenesis. EMBO J 26:4177, 2007.
73. Stavnezer J, Guikema JE, Schrader CE: Mechanism and regulation of class switch 107. Reddy PS, Corley RB: The contribution of ER quality control to the biologic functions
recombination. Annu Rev Immunol 26:261, 2008. of secretory IgM. Immunol Today 20:582, 1999.
74. Ferrari SPlebani A: Cross-talk between CD40 and CD40L: Lessons from primary 108. Frey S, Haslbeck M, Hainzl O, Buchner J: Synthesis and characterization of a functional
immune deficiencies. Curr Opin Allergy Clin Immunol 2:489, 2002. intact IgG in a prokaryotic cell-free expression system. Biol Chem 389:37, 2008.
75. Cerutti A: The regulation of IgA class switching. Nat Rev Immunol 8:421, 2008. 109. Rudd PM, Elliott T, Cresswell P, et al: Glycosylation and the immune system. Science
76. Mora JR, von Andrian UH: Differentiation and homing of IgA-secreting cells. Mucosal 291:2370, 2001.
Immunol 1:96, 2008. 110. Jefferis R: Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev
77. Yamane A, Robbiani DF, Resch W, et al: RPA accumulation during class switch recom- Drug Discov 8:226, 2009.
bination represents 5′-3′ DNA-end resection during the S-G2/M phase of the cell cycle. 111. Johnston RJ, Poholek AC, DiToro D, et al: Bcl6 and Blimp-1 are reciprocal and antago-
Cell Rep 3:138, 2013. nistic regulators of T follicular helper cell differentiation. Science 325:1006, 2009.

Kaushansky_chapter 75_p1159-1174.indd 1173 9/21/15 12:12 PM